70301-1001 : Rayaldee 30 ug/1 Oral Capsule, Extended Release
| NDC: | 70301-1001 |
| Labeler: | Opko Pharmaceuticals LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Rayaldee |
| Dosage Form: | Oral Capsule, Extended Release |
| Application #: | NDA208010 |
| Rev. Date: |
Appearance:
| Markings: | O |
| Shapes: |
Oval |
| Colors: |
 Blue |
| Size (mm): | 12 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 70301-1001-1: 30 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (70301‑1001‑1)
- 70301-1001-2: 60 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (70301‑1001‑2)
- 70301-1001-3: 7 CAPSULE, EXTENDED RELEASE IN 1 BOTTLE (70301‑1001‑3)
Active Ingredients:
- Calcifediol
Dosage Strength:
- 30 ug/1
Inactive Ingredients:
- Paraffin
- Mineral Oil
- Hypromelloses
- Diacetyltartaric and Fatty Acid Esters of Glycerol
- Lauroyl Peg-32 Glycerides
- Alcohol
- Butylated Hydroxytoluene
- Medium-chain Triglycerides
- Hydroxypropyl Corn Starch (5% Substitution by Weight)
- Carrageenan
- Sodium Phosphate, Dibasic
- Sorbitol
- Sorbitan
- Fd&c Blue No. 1
- Titanium Dioxide
- Water
- Isopropyl Alcohol
- Propylene Glycol
Pharmaceutical Classes:
- Cholecalciferol [CS]
- Vitamin D3 Analog [EPC]
Related Products:
Based on records with the same trade name.- 70301-1002 Rayaldee 30 ug/1 Oral Capsule, Extended Release by Opko Pharmaceuticals LLC
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70300-001Next: 70301-1002 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.